Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 65

    1.

    The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.

    Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC.

    Cancer Prev Res (Phila Pa). 2009 Sep;2(9):830-41. Epub 2009 Sep 8.PMID: 19737984 [PubMed - indexed for MEDLINE]Related articles

    2.

    Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.

    Melstrom LG, Salabat MR, Ding XZ, Milam BM, Strouch M, Pelling JC, Bentrem DJ.

    Pancreas. 2008 Nov;37(4):426-31.PMID: 18953257 [PubMed - indexed for MEDLINE]Related articles

    3.

    Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR.

    Tong X, Pelling JC.

    Mol Carcinog. 2009 Feb;48(2):118-29.PMID: 18680106 [PubMed - indexed for MEDLINE]Related articles

    4.

    Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures.

    Abu-Yousif AO, Smith KA, Getsios S, Green KJ, Van Dross RT, Pelling JC.

    Cancer Res. 2008 Apr 15;68(8):3057-65.PMID: 18413777 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines.

    Salabat MR, Melstrom LG, Strouch MJ, Ding XZ, Milam BM, Ujiki MB, Chen C, Pelling JC, Rao S, Grippo PJ, McGarry TJ, Bentrem DJ.

    Mol Carcinog. 2008 Nov;47(11):835-44.PMID: 18404646 [PubMed - indexed for MEDLINE]Related articles

    6.

    Dietary genistein inhibits metastasis of human prostate cancer in mice.

    Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC.

    Cancer Res. 2008 Mar 15;68(6):2024-32.PMID: 18339885 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.

    Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, Pelling JC.

    Mol Carcinog. 2008 Sep;47(9):686-700.PMID: 18240292 [PubMed - indexed for MEDLINE]Related articles

    8.

    Modulation of UVB-induced and basal cyclooxygenase-2 (COX-2) expression by apigenin in mouse keratinocytes: role of USF transcription factors.

    Van Dross RT, Hong X, Essengue S, Fischer SM, Pelling JC.

    Mol Carcinog. 2007 Apr;46(4):303-14.PMID: 17186551 [PubMed - indexed for MEDLINE]Related articles

    9.

    Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition.

    Tong X, Van Dross RT, Abu-Yousif A, Morrison AR, Pelling JC.

    Mol Cell Biol. 2007 Jan;27(1):283-96. Epub 2006 Oct 30.PMID: 17074806 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Do truncated cyclins contribute to aberrant cyclin expression in cancer?

    Van Dross R, Browning PJ, Pelling JC.

    Cell Cycle. 2006 Mar;5(5):472-7. Epub 2006 Mar 1. Review.PMID: 16552186 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Inhibition of TPA-induced cyclooxygenase-2 (COX-2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes.

    Van Dross RT, Hong X, Pelling JC.

    Mol Carcinog. 2005 Oct;44(2):83-91.PMID: 16044407 [PubMed - indexed for MEDLINE]Related articles

    12.

    The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines.

    Van Dross R, Xue Y, Knudson A, Pelling JC.

    J Nutr. 2003 Nov;133(11 Suppl 1):3800S-3804S.PMID: 14608117 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.

    Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC, Grantham JJ.

    Kidney Int. 2003 Jun;63(6):1983-94.PMID: 12753285 [PubMed - indexed for MEDLINE]Related articles

    14.

    Association of JNK1 with p21waf1 and p53: modulation of JNK1 activity.

    Xue Y, Ramaswamy NT, Hong X, Pelling JC.

    Mol Carcinog. 2003 Jan;36(1):38-44.PMID: 12503078 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.

    Cui W, Yazlovitskaya EM, Mayo MS, Pelling JC, Persons DL.

    Mol Carcinog. 2000 Dec;29(4):219-28.PMID: 11170260 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of the (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo.

    Mahadevan B, Luch A, Seidel A, Pelling JC, Baird WM.

    Carcinogenesis. 2001 Jan;22(1):161-9.PMID: 11159755 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin.

    Persons DL, Yazlovitskaya EM, Pelling JC.

    J Biol Chem. 2000 Nov 17;275(46):35778-85.PMID: 10958792 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.

    Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF.

    Mol Carcinog. 2000 Jun;28(2):102-10.PMID: 10900467 [PubMed - indexed for MEDLINE]Related articles

    20.

    cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

    Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ.

    Kidney Int. 2000 Apr;57(4):1460-71.PMID: 10760082 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...